Gluskin Sheff & Assoc Inc Merck & Co., Inc. Transaction History

Gluskin Sheff & Assoc Inc

  • $832 Million
  • Q2 2024

A detailed history of Gluskin Sheff & Assoc Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 26,652 shares of MRK stock, worth $2.99 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
26,652
Previous 26,673 0.08%
Holding current value
$2.99 Million
Previous $3.52 Million 6.25%
% of portfolio
0.4%
Previous 0.37%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$123.8 - $132.96 $2,599 - $2,792
-21 Reduced 0.08%
26,652 $3.3 Million
Q1 2024

May 15, 2024
SELL
$113.24 - $131.95 $1.95 Million - $2.27 Million
-17,183 Reduced 39.18%
26,673 $3.52 Million
Q4 2023

Feb 14, 2024
SELL
$100.18 - $109.02 $1.4 Million - $1.52 Million
-13,963 Reduced 24.15%
43,856 $4.78 Million
Q3 2023

Nov 14, 2023
SELL
$102.95 - $114.33 $1.09 Million - $1.21 Million
-10,557 Reduced 15.44%
57,819 $5.95 Million
Q2 2023

Aug 14, 2023
SELL
$108.61 - $118.38 $1.13 Million - $1.24 Million
-10,450 Reduced 13.26%
68,376 $7.89 Million
Q1 2023

May 15, 2023
SELL
$102.94 - $114.86 $1.39 Million - $1.55 Million
-13,480 Reduced 14.6%
78,826 $8.39 Million
Q4 2022

Feb 14, 2023
BUY
$87.44 - $112.11 $116,732 - $149,666
1,335 Added 1.47%
92,306 $10.2 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $608,277 - $683,332
7,196 Added 8.59%
90,971 $7.83 Million
Q2 2022

Aug 15, 2022
BUY
$83.49 - $94.64 $793,238 - $899,174
9,501 Added 12.79%
83,775 $7.64 Million
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $84,095 - $94,265
-1,144 Reduced 1.52%
74,274 $6.09 Million
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $451,460 - $565,512
6,246 Added 9.03%
75,418 $5.78 Million
Q3 2021

Nov 12, 2021
BUY
$71.68 - $78.83 $62,576 - $68,818
873 Added 1.28%
69,172 $5.2 Million
Q2 2021

Aug 13, 2021
SELL
$70.31 - $77.77 $99,066 - $109,577
-1,409 Reduced 2.02%
68,299 $5.31 Million
Q1 2021

May 14, 2021
SELL
$68.86 - $81.11 $729,089 - $858,792
-10,588 Reduced 13.19%
69,708 $5.37 Million
Q4 2020

Feb 16, 2021
SELL
$71.77 - $79.65 $1.43 Million - $1.58 Million
-19,890 Reduced 19.85%
80,296 $6.57 Million
Q3 2020

Nov 12, 2020
SELL
$73.18 - $82.95 $82,254 - $93,235
-1,124 Reduced 1.11%
100,186 $8.31 Million
Q2 2020

Aug 11, 2020
SELL
$70.42 - $80.13 $1.85 Million - $2.1 Million
-26,224 Reduced 20.56%
101,310 $7.84 Million
Q1 2020

May 13, 2020
BUY
$63.36 - $87.82 $1.29 Million - $1.79 Million
20,344 Added 18.98%
127,534 $9.81 Million
Q4 2019

Feb 12, 2020
SELL
$77.58 - $87.54 $58,960 - $66,530
-760 Reduced 0.7%
107,190 $9.55 Million
Q3 2019

Nov 08, 2019
BUY
$76.08 - $82.93 $8.21 Million - $8.95 Million
107,950 New
107,950 $9.09 Million

Others Institutions Holding MRK

# of Institutions
3,829
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email